Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

HKG:0719 Revenue

Shandong Xinhua Pharmaceutical Company had revenue of 1.93B CNY in the quarter ending June 30, 2026, a decrease of -12.43%. This brings the company's total for the last twelve months to 8.47B, up 1.20% year-over-year. In the year 2025, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.75B with 3.41% growth. That makes Shandong Xinhua Pharmaceutical Company the 6,695th largest company in the world by revenue and 428th in Hong Kong.

• Revenue (ttm): 8.47B CNY
• Revenue Growth: +1.20%
• P/S Ratio: 0.90
• Revenue / Employee: 1.21M CNY
• Employees: 7,015
• Market Cap: 8.56B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Preparations 4.85B 45.6%
• Pharmaceutical Intermediates and other Products 3.13B 29.4%
• Chemical Raw Materials 2.66B 25.0%

By Geography

Chart

• China (Including Hong Kong) 6.79B 77.5%
• Americas 745.57M 8.5%
• Europe 712.82M 8.1%
• Others 511.11M 5.8%

Fiscal year ended Dec 31, 2025 See the full HKG:0719 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.75B	288.41M	3.41%
Dec 31, 2024	8.47B	365.47M	4.51%
Dec 31, 2023	8.10B	597.86M	7.97%
Jan 1, 2023	7.50B	942.91M	14.37%
Dec 31, 2021	6.56B	554.49M	9.23%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error